Affimer News and Research

RSS
Avacta and Medusa19 enter into a distribution agreement for COVID-19 antigen test

Avacta and Medusa19 enter into a distribution agreement for COVID-19 antigen test

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

Developing a COVID-19 antigen test

Developing a COVID-19 antigen test

Avacta Group plc forms COVID-19 antigen diagnostic collaboration with Adeptrix

Avacta Group plc forms COVID-19 antigen diagnostic collaboration with Adeptrix

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Avacta partners with Cytiva to develop a rapid test for COVID-19

Avacta partners with Cytiva to develop a rapid test for COVID-19

Avacta demonstrates initial proof-of-concept for TMAC drug conjugates in pre-clinical study

Avacta demonstrates initial proof-of-concept for TMAC drug conjugates in pre-clinical study

Avacta and Daewoong Pharmaceutical announce joint venture to develop novel cell and gene therapies

Avacta and Daewoong Pharmaceutical announce joint venture to develop novel cell and gene therapies

LG Chem Life Sciences expands collaboration with Avacta

LG Chem Life Sciences expands collaboration with Avacta